Tablet Use Encourages Patients to Explore Diabetes Risk

Share this content:
Tablet Use Encourages Patients to Explore Diabetes Risk
Tablet Use Encourages Patients to Explore Diabetes Risk

WEDNESDAY, Aug. 23, 2017 (HealthDay News) -- The multispecialty San Bernardino Medical Group has replaced magazines with digital devices in waiting rooms, which can help patients learn about their risk of diabetes and take preventive action, according to a report published by the American Medical Association (AMA).

As part of its work to improve health outcomes, the AMA has collaborated with Outcome Health to provide devices to physician practices. These devices are designed to help patients identify their prediabetes risk, enable productive conversation with providers, and allow physicians to refer patients at risk to diabetes prevention programs.

Nurses encourage patients to use the tablets as they wait for a physician, and patients are instructed to take the prediabetes risk assessment before their consultation. Nurses and physicians are educating patients to become familiar with the system and what content is on the tablets. The practice has a diabetes educator who uses an Outcome Health tablet in her education room and works with patients to discuss the diabetes education program as well as diet and exercise and other areas needed for a healthier lifestyle. As patients often have to wait for a physician, the availability of digital educational prediabetes materials makes use of this time in a meaningful way.

"With modern technology, we've eliminated the magazines and encourage patients to utilize the tablets," said practice administrator Vanessa Bales, according to the AMA.

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »